[1] Gupta AR, Shah NR, Patel TC, et al. Perioperative and long-term complications of iliac crest bone graft harvesting for spinal surgery: a quantitative review of the literature
[J]. Int Med J, 2001,8(9):63-66.
[2] Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with cDNA encoding a novel osteoinductive protein (LMP-1)
[J].Spine,1998,23(23):2486-2492.
[3] Lawrence JP, Ennis F, White AP, et al. Effect of daily parathyroid hormone (1-34) on lumbar fusion in a rat model
[J].Spine, 2006, 6(4):385-390.
[4] Abe Y, Takahata M, Ito M, et al. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model
[J].Bone, 2007,41(5):775-785.
[5] Huang RC, Khan SN, Sandhu HS, et al. Alendronate inhibits spine fusion in a rat model
[J].Spine,2005,30(22):2516-2522.
[6] Grauer JN, Bomback DA, Lugo R, et al. Posterolateral lumbar fusions in athymic rats:characterization of a model
[J]. Spine,2004,4(3):281-286.
[7] O'Loughlin PF, Cunningham ME, Bukata SV, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model
[J]. Spine,2009,34(2):121-130.
[8] Grauer JN, Patel TC, Erulkar JS, et al. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion
[J]. Spine,2001,26(2):127-133.
[9] Steinmann JC, Herkowitz N. Pseudarthosis of the spine
[J].Clin Orthop,1992,(284):80-90.
[10]Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics
[J]. Spine,1995,20(4):412-420.